TheraVitae was established in 2003 and includes an R&D Center in Israel and a state-of-the-art Operating Center in Bangkok. It has treated over 200 patients to date, with high levels of safety and efficacy. There have also been over 30 patients treated on a clinical trial basis.

TheraVitae also has 6 pending US patents on a variety of research breakthroughs and is running active clinical trial programs in Hong Kong, Israel, Thailand and India. It features over 60 affiliate hospitals which use commercial applications of VesCell technology.